Apollo Hospitals’ healthy Q4 earnings combined with the management’s upbeat guidance for growth in the ongoing fiscal has ushered optimism among brokerages. After reporting a slight beat on both net profit and revenue for the March quarter, Apollo’s management guided for a mid-teen growth in its core hospital business for FY25.
Additionally, the firm projected an EBITDA margin of 25 percent by the end of FY25 for its hospital business, along with plans to take occupancy levels close to 70 percent. The management stated its focus on increasing volumes, insurance tie-ups, and international patients to achieve the occupancy target, which should reflect in higher occupancy rates.
The robust performance and positive outlook have fueled optimism among brokerages across the board. As of 10:20 am, Apollo Hospitals’ shares were trading at ₹5,876.45, reflecting the positive sentiment surrounding the company’s prospects.
